1. Introduction {#sec1}
===============

Cardiovascular diseases (CVDs) are the leading causes of death globally accounting for almost 30% of deaths worldwide \[[@B1]\]. The development of CVDs has a generally long prodromal period with clinical symptoms only becoming apparent after considerable damage, and remodelling has already occurred in the vascular endothelium. It has been shown that carotid intima-media thickness (CIMT) ultrasonography represents a sensitive and reliable method to detect the presence and progression of subclinical vascular changes that if left unchecked portend CVD \[[@B2]\]. However, in a recent study, more than half of CIMT variance was not explained by conventional cardiovascular risk factors such as dyslipidaemia \[[@B3]\]. Unfortunately, biochemical abnormalities such as high plasma total cholesterol are now recognized as downstream secondary pathologies, not as primary initiators of the disease process and therefore may not closely reflect actual disease, particularly in the early stages \[[@B4]\]. Thus, the identification of biomarkers for which the change more specifically represents the disease process and is therefore more indicative of the presence of tissue damage is needed.

It has been shown that biochemical changes associated with redox imbalance and oxidative stress are associated with the endothelial remodelling involved in atherosclerosis and increased CIMT \[[@B5], [@B6]\]. In addition, it has been reported that biomarkers of oxidative stress are significantly associated with the risk of atherosclerosis and CIMT even after controlling for conventional risk factors \[[@B7]\]. In other words, while generally not included in routine pathology measures such as plasma lipid profile, this chronic subclinical disease process may be detected via changes in oxidative stress biomarkers. This is consistent with the observation that oxidized low-density lipoprotein cholesterol (LDL-C) has been shown to be more atherogenic than native LDL-C \[[@B4]\]. Therefore, including a measure of oxidative stress in any risk assessment tool may add further value to the current set of conventional risk factors used for disease prediction and prognosis.

The role of unhealthy lifestyle behaviours as primary driving forces behind the development of CVDs has been well established \[[@B1]\]. Continuous exposure to unhealthy lifestyle behaviours, with high prooxidant and low antioxidant potentials, has been shown to significantly affect the redox balance causing oxidative stress and subsequent chronic cell damage \[[@B8]\]. Through years of chronic exposure, this damage accumulates and gradually drives the body toward a diseased phenotype \[[@B9]\]. Therefore, an early evaluation of the effect of lifestyle behaviours on the redox balance may be helpful in assessing whether an individual\'s lifestyle is driving their biochemistry toward either health or disease.

Much of the literature addressing the association between lifestyle behaviours, CVD risk, and oxidative stress has focused on the independent effects of individual lifestyle behaviours \[[@B10]--[@B14]\]. However, considering the potential for complex interactions between multiple lifestyle factors \[[@B15]--[@B17]\], a combination of several oxidative stress-related lifestyle factors, as a unified score, may be more strongly associated with health outcomes than any individual factor. While some studies have developed indices or scores that account for multiple lifestyle components, assessments of their effects on redox balance have been limited to lifestyle components such as dietary antioxidants/prooxidants, smoking, and medication use \[[@B18], [@B19]\]. In addition, their assessments have yielded conflicting results \[[@B18]\]. More importantly, none has investigated the association between an oxidative stress-related lifestyle score and a subclinical indicator of CVD, such as high CIMT. Hence, the associations between a redox balance lifestyle score, the risk for higher CIMT, and biomarkers of oxidative stress remain unclear. Therefore, in this study, we aimed to examine the association between a more comprehensive lifestyle score that included lifestyle factors previously shown to influence redox balance (i.e., redox balance lifestyle score (RBLS)) and risk for higher CIMT as a recognized subclinical marker for CVD. Secondarily, we investigated whether this RBLS also correlates with plasma biomarkers of oxidative stress and other conventional risk factors for atherosclerosis in otherwise healthy subjects. To the best of our knowledge, this is the first study to investigate these associations in an apparently healthy cohort.

2. Materials and Methods {#sec2}
========================

2.1. Participants {#sec2.1}
-----------------

In this cross-sectional study, 100 apparently healthy subjects (48 males and 52 females), aged between 40 and 75 years, were recruited at Sydney Adventist Hospital and the University of New South Wales campuses. After obtaining a written informed consent, participants were asked to complete a series of questionnaires for the assessment of their lifestyle behaviours. Participants were asked to recall their lifestyle behaviours over the past four months. All questionnaires (except dietary questionnaires) were completed online a maximum of two weeks before the blood collection and physiological assessments. Hard copies of dietary questionnaires were completed on the same day as the blood collection and physiological assessments. Blood collection, blood pressure measurement, and body scanning for visceral adipose tissue (VAT) fat mass analysis were all performed on the same day in a fasted state (about 12 hours). Ethical approval of the study was obtained from the Adventist HealthCare Limited Human Research Ethics Committee, Sydney Adventist Hospital, Australia (HREC number: 2013-022).

2.2. Biochemical Analysis {#sec2.2}
-------------------------

Plasma total antioxidant capacity and reactive oxygen species (in the form of hydroperoxides) were measured indirectly using the FORD (free oxygen radicals defence) and the FORT (free oxygen radical test) colorimetric assays (CR3000, Callegari Srl., Catellani Group, Parma, Italy), as previously described \[[@B20]\]. Plasma C-reactive protein (CRP) levels were quantified by immunoturbidimetric assay on a Roche/Hitachi cobas c system (Sydney Adventist Hospital pathology laboratory). Plasma tumour necrosis factor-*α* (TNF-*α*), interleukin-1*β* (IL-1*β*), and IL-6 levels were measured using the MILLIPLEX® MAP human high-sensitivity T-cell magnetic bead panel immunoassay (Merck KGaA, Darmstadt, Germany).

Measurements of fasting plasma glucose (FPG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), uric acid (UA), and *γ*-glutamyltransferase (GGT) levels were conducted by the Sydney Adventist Hospital pathology laboratory on a Roche/Hitachi cobas c system using the enzymatic method. Plasma-glycated hemoglobin A1c (HbA1c) concentration was measured by ion-exchange high-performance liquid chromatography (HPLC) on the D-100 hemoglobin testing system (Bio-Rad Laboratories, Hercules, CA, USA).

Low-density lipoprotein cholesterol (LDL-C) levels were calculated by the Friedewald equation \[[@B21]\]. TyG index was calculated as the ln \[fasting triglycerides (mmol/L) × fasting glucose (mmol/L)/2\] \[[@B22]\].

2.3. Visceral Fat Mass Analysis {#sec2.3}
-------------------------------

Dual-energy X-ray absorptiometry (DXA) method was used to measure VAT fat mass by a Lunar iDXA (GE Healthcare, Madison, WI, USA) with an automatic total-body scan mode and enCORE software (version 16, GE Healthcare, Madison, WI, USA). After being changed into a standard cloth gown, participants were correctly centred on the scanning table in a supine position and then were scanned by a trained operator according to the standard methods previously described \[[@B23]\].

2.4. Common Carotid Intima-Media Thickness (CIMT) Measurement {#sec2.4}
-------------------------------------------------------------

IMT measurements of the right common carotid artery (CCA) were obtained after placing the participant in a supine position and having them rotate their neck to the left. Orientation to the CCA was achieved by first using a transversal scanning view from the base of the neck to the carotid bifurcation. At approximately 1 cm below the bifurcation, the transducer was rotated to obtain a longitudinal image of the vessel. At least three representative measurements of CIMT were made in the far wall in the most thickened area of each vessel, while plaques were not included. The mean of these three measurements was then calculated and reported in the study. Optimal B-mode settings for gain, depth, and focal zone placement were adjusted to enhance arterial wall structures and image quality for each individual. IMT was measured by manually applying electronic callipers \[[@B24]\].

2.5. Questionnaires {#sec2.5}
-------------------

For assessing dietary and alcohol intake, the validated 74-item Cancer Council Victoria Dietary Questionnaire for Epidemiological Studies Version 2 (DQES v2) \[[@B25]\] was used. The evaluation of caffeine intake, physical activity level, sitting time, depression, anxiety and stress, sleep quality, and sleep apnoea risk was conducted by using the validated Stanford questionnaire \[[@B26]\], International Physical Activity Questionnaire (IPAQ)---long version \[[@B27]\], Depression Anxiety Stress Scale-21 (DASS-21) questionnaire; Pittsburgh Sleep Quality Index (PSQI) \[[@B29]\], and Berlin questionnaires \[[@B30]\], respectively.

2.6. Statistical Analysis {#sec2.6}
-------------------------

The Shapiro-Wilk and Kolmogorov-Smirnov tests were applied to test the normality of the variables. After checking graphical displays and applying appropriate statistical rules, the following outliers were removed: one outlier was removed from the data for each of the variables stress score, anxiety score, sitting time, intakes of lycopene, *α*-carotene, *β*-carotene, polyunsaturated fatty acid (PUFA), iron, vitamin E and alcohol, plasma IL-6, TNF-*α*, TAC, and hydroperoxide. Therefore, *n* = 99 for each of these variables. In addition, one outlier was removed and one missing value was reported for the variable carotid intima-media thickness resulting in *n* = 98 for this variable. Two outliers were removed for the variables PSQI, depression score, intakes of caffeine and *β*-cryptoxanthin, plasma uric acid, and carotenoid resulting in *n* = 98 for each of these variables. Three outliers were removed for the variables vitamin C intake, VAT fat mass, plasma IL-1*β*, TG, CRP, GGT, and TG/HDL-C resulting in *n* = 97 for each of these variables. Correlations between variables were analyzed using Pearson\'s (*r*(*n*)) or Spearman\'s (*r*~s~(*n*)) correlation coefficients, as deemed appropriate. Multiple linear regression analysis was performed to examine the association between the RBLS and plasma levels of oxidative stress and inflammatory markers as well as other biochemical marker levels, after adjustment for age and gender. The Levene\'s test of equality was used to check the homogeneity of variances between groups. If normality tests for the variables or multiple linear regression models were significant, then an appropriate transformation of the data was performed so that normality assumptions were satisfied. Transformation techniques included base-10 log-transformed means, square roots, or reciprocal roots.

Logistic regression analysis was used to examine the association between the high CIMT risks and the RBLS. The median value was used to dichotomize the CIMT measure. Also, in order to allow a quantitative comparison of risks in persons at different ends of the exposure distribution, the RBLS was divided into two categories. All models were examined for collinearity among the independent variables. Linearity of any continuous independent variables and the logit transformation of the dependent variable were checked using the Box-Tidwell procedure. Whenever the distribution of a variable was significantly different from the normal distribution, we transformed that variable by using the power of 2 or the square root of the related independent variables was used. The results of the logistic regression models were expressed as adjusted odds ratios (ORs) and 95% CIs. All statistical analyses were performed using SPSS version 23 for Windows. *P* values less than 0.05 were considered statistically significant.

2.7. Redox Balance Lifestyle Score Definition {#sec2.7}
---------------------------------------------

The redox balance lifestyle score (RBLS) was developed with reference to the previously validated oxidative balance score (OBS) \[[@B18]\]. OBS was comprised of lifestyle components with prooxidant and antioxidant properties including nutritional subcomponents, alcohol intake, smoking, and medication and supplement use. In order to provide a better estimation of the redox balance state, additional lifestyle behaviours with established evidence of their association with oxidative stress were included in the score calculation. These include intakes of transfatty acids \[[@B31]\] and caffeine \[[@B15]\]; psychological wellness \[[@B13]\]; sleeping behaviours \[[@B14]\]; physical activity \[[@B10]\]; and, for the first time, a measure of VAT fat mass, a well-known prooxidant risk factor for NCDs \[[@B32]\]. As all participants had been asked to stop taking medications or supplements at least two weeks prior to testing day, we did not take into account medication or supplement use.

The total score ranged from 4.54 to 9.05 points, with a higher score reflecting a better redox balance state ([Table 1](#tab1){ref-type="table"}). All continuous score variables were divided into tertiles on the basis of the distribution of these variables among the participants of the study. The exception was for alcohol intake that was categorized as abstainer, one drink per day, and greater than 1 drink per day intakes, due to a significant number of abstainers in the cohort. The qualitative variable of apnoea risk was divided into two categories (low and high) based on the related questionnaire\'s scoring system. The smoking history cutoffs were defined by assigning one point to current smokers, two points to ever smokers, and three points to never smokers. Subjects who had values for components with antioxidant properties in the first, second, and third tertiles were assigned one, two, and three points, respectively. Subjects who had values for components with prooxidant properties in the first, second, and third tertiles were assigned three points, two points, and one point, respectively ([Table 1](#tab1){ref-type="table"}).

In order to calculate the final RBLS, a raw score was first calculated for each person for each lifestyle component based on the scoring system described above. The raw score for each lifestyle component was then weighted by multiplying it by the (absolute) correlation coefficient of the association between the relevant component and the plasma TAC/HPX ratio ([Table 1](#tab1){ref-type="table"}), a meaningful measure of redox balance \[[@B33]\]. Importantly, the potential for prooxidant effects due to excess antioxidant vitamin intake (e.g., vitamin E, vitamin C, or *β*-carotene) was accounted for by assigning a value of one to intakes higher than levels previously linked to oxidative activity \[[@B34], [@B35]\] for the related antioxidant. However, in this cohort, antioxidant vitamin intake values were below these pro-oxidant-linked values.

3. Results {#sec3}
==========

Among a total of 100 subjects, 48 were males. Participant characteristics for individual components and their association with the redox balance lifestyle score (RBLS) are shown in [Table 2](#tab2){ref-type="table"}. The participants\' possible score can range between 4.54 (least healthy) and 9.05 (most healthy). The overall mean ± SD for the RBLS for the cohort was 6.69 ± 0.90. Statistically significant correlations were found between individual components and the overall RBLS as shown in [Table 2](#tab2){ref-type="table"}. *β*-Carotene intake had the strongest association while transfatty acid and iron intakes had the weakest associations with the RBLS.

3.1. Association between the Redox Balance Lifestyle Score (RBLS) and Carotid Intima-Media Thickness (CIMT) {#sec3.1}
-----------------------------------------------------------------------------------------------------------

[Table 3](#tab3){ref-type="table"} shows the logistic regression analysis results for the association between redox balance lifestyle score (RBLS) and risk of higher CIMT. The logistic regression analysis showed that after adjustment for age and gender, there was a statistically significant (*χ*^2^(3) = 23.61, *P* ≤ 0.001) association between CIMT and the RBLS that explained 28.6% (Nagelkerke *R*^2^) of the variance in CIMT. Those with scores below the median (i.e., ≤6.68) were at significantly increased risk of higher CIMT compared to those with scores above the median (OR = 4.11, 95% CI: 1.57--10.75, *P* = 0.004).

Importantly, these associations remained significant after additional adjusting for conventional atherosclerosis risk factors including systolic and diastolic blood pressures, LDL-cholesterol, eGFR, FPG, and TG/HDL-C (*χ*^2^(9) = 35.60, *P* ≤ 0.001), where the adjusted model then explained 42.4% (Nagelkerke *R*^2^) of the variance in CIMT. After adjustment, those with the RBLS below the median (i.e., ≤6.68) were at a significantly increased risk of higher CIMT compared to participants with scores above the median (OR = 3.60, 95% CI: 1.19--10.88, *P* = 0.023).

3.2. Association between the Redox Balance Lifestyle Score (RBLS) and Oxidative Stress and Inflammatory Markers {#sec3.2}
---------------------------------------------------------------------------------------------------------------

[Table 4](#tab4){ref-type="table"} shows the associations between the RBLS and levels of plasma biomarkers of oxidative stress and inflammation. A statistically significant positive association was observed between the RBLS and total antioxidant capacity (TAC) (*r*(99) = 0.28, *P* = 0.006). Since the residuals for the linear regression model were not normally distributed when gender was included, the association between the RBLS and plasma TAC was analyzed separately for each gender. The results showed that after controlling for age, there was a statistically significant association between the RBLS and TAC in males (*t*(45) = 3.71, *P* = 0.001, *R*^2^ = 0.20) but not in females (*t*(48) = 0.98, *P* ≥ 0.05, *R*^2^ = −0.02). A statistically significant negative association was observed between the RBLS and plasma hydroperoxide levels (*r*~s~(99) = −0.28, *P* = 0.005). This association remained significant after the adjustment for age and gender (*t*(95) = −3.02, *P* = 0.003, *R*^2^ = 0.31).

There was a statistically significant negative association between the RBLS and the plasma oxidative stress-associated enzyme GGT (*r*(97) = −0.23, *P* = 0.024). This association remained significant after adjustment for age and gender (*t*(93) = −2.31, *P* = 0.023, *R*^2^ = 0.10).

The RBLS was significantly negatively associated with plasma uric acid (*r*(98) = −0.20, *P* = 0.045). This association remained significant after age and gender adjustment (*t*(94) = −2.43, *P* = 0.017, *R*^2^ = 0.30).

As anticipated, the RBLS was statistically significantly associated with the TAC/HPX ratio (*r*(98) = 0.41, *P* ≤ 0.001), an index of redox balance ([Figure 1](#fig1){ref-type="fig"}). This association remained significant after adjustment for age and gender (*t*(94) = 4.40, *P* ≤ 0.001, *R*^2^ = 0.20).

There was a statistically significant negative association between the RBLS and the plasma inflammatory marker IL-1*β* (*r*(97) = −0.21, *P* = 0.04). This association did not remain significant after adjustment for age and gender (*t*(93) = −2.06, *P* ≥ 0.05, *R*^2^ = 0.05). The RBLS was also significantly associated with the acute-phase plasma inflammatory protein CRP (*r*~s~(97) = −0.25, *P* = 0.012). However, this association did not remain significant after age and gender adjustment (*t*(93) = −2.36, *P* ≥ 0.05, *R*^2^ = 0.04). No significant association was observed between the RBLS and plasma TNF-*α* (*r*(99) = −0.06, *P* ≥ 0.05) and IL-6 (*r*(98) = −0.07, *P* ≥ 0.05).

3.3. Association between the RBLS and Routine Pathology Biomarkers {#sec3.3}
------------------------------------------------------------------

A statistically significant negative association was observed between the RBLS and both plasma cholesterol (*r*(100) = −0.34, *P* ≤ 0.001) and LDL-C levels (*r*(100) = −0.32, *P* = 0.001). Both of these associations remained significant after adjustment for age and gender (*t*(96) = −3.63, *P* ≤ 0.001, *R*^2^ = 0.12 and *t*(96) = −3.42, *P* = 0.001, *R*^2^ = 0.11, resp.). There was no significant association between the RBLS and plasma HDL-C (*r*(100) = 0.12, *P* ≥ 0.05).

There was a statistically significant inverse association between the RBLS and plasma triglycerides (*r*~s~(97) = −0.32, *P* = 0.002). This association remained significant after adjusting for age and gender (*t*(93) = −3.81, *P* ≤ 0.001, *R*^2^ = 0.15).

A statistically significant inverse association was observed between the RBLS and both plasma glucose (*r*(100) = −0.30, *P* = 0.003) and HbA1c (*r*(95) = −0.23, *P* = 0.025). After adjustment for age and gender, the association between RBLS and plasma glucose remained significant (*t*(96) = −3.22, *P* = 0.002, *R*^2^ = 0.12). However, the association between RBLS and plasma HbA1c did not remain significant after adjustment for age and gender (*t*(91) = −2.39, *P* ≥ 0.05, *R*^2^ = 0.05).

Not surprisingly, a strong inverse association was observed between the RBLS and the plasma TG/HDL-C ratio (a measure of insulin resistance) (*r*(97) = −0.27, *P* = 0.008). This association remained significant after adjusting for age and gender (*t*(91) = −2.99, *P* = 0.004, *R*^2^ = 0.22).

Furthermore, a strong inverse association was observed between the RBLS and plasma TyG index (an additional measure of insulin resistance) (*r*(100) = −0.40, *P* ≤ 0.001). Since the residuals for the linear regression model were not normally distributed when gender was included, the association between the RBLS and plasma TyG index was analyzed separately for each gender. The results showed that after controlling for age, there was a statistically significant association between the RBLS and TyG index in both males (*t*(45) = −3.53, *P* ≤ 0.001, *R*^2^ = 0.18) and females (*t*(49) = −2.60, *P* = 0.012, *R*^2^ = 0.09).

4. Discussion {#sec4}
=============

Oxidative stress (OS), defined as an imbalanced state between an organ\'s exposure to reactive oxygen species and the body\'s compensatory antioxidant defence \[[@B36]\], is a recognized player in the progressive cell damage involved in the development of CVD \[[@B4]\]. The specific impact of individual lifestyle components, with both pro- and antioxidant elements, on oxidative stress and the consequent development of several diseases including CVD have been a focus of attention in the literature for some time \[[@B10], [@B37]--[@B39]\]. However, as suggested by some investigators, it is not the individual but the cumulative action of all lifestyle factors working together that eventually affects the redox balance and determines an individual\'s risk of disease. In this context, some studies have reported associations between a composite lifestyle score and increased risk for several diseases \[[@B40], [@B41]\]. However, assessments of multiple lifestyle elements have been limited to a score comprising only a few pro- and antioxidant lifestyle factors with uncertain effect on oxidative stress biomarkers \[[@B18], [@B19]\]. Furthermore, no study has yet assessed the association between a composite oxidative stress-related lifestyle score and the subclinical vascular changes represented by CIMT. While one large study has reported an association between a seven-point cardiovascular health score and CIMT, its assessment was limited to only four lifestyle components with no reference to oxidative stress \[[@B42]\]. Therefore, in this study, we aimed to assess the association between a more comprehensive redox balance lifestyle score (RBLS) and CIMT. We also investigated the association between RBLS, oxidative stress and inflammatory biomarkers.

As expected, significant correlations were observed between individual lifestyle components and the overall RBLS ([Table 2](#tab2){ref-type="table"}). All significant associations were in accordance with expected direction, with poorer lifestyle habits associated with increased oxidative stress.

In order to compare CIMT risks in subjects at different ends of the score distribution, the RBLS and CIMT values were divided into two groups using median values as the cutoffs. Logistic regression analysis showed that a lower RBLS was associated with a higher CIMT risk after adjusting for age and gender. More surprisingly, this association remained significant after further adjusting for conventional atherosclerosis risk factors including systolic and diastolic blood pressures, LDL-cholesterol, eGFR, FPG, and TG/HDL-C ratio. Subjects with scores below the median were 3.60 times more likely to exhibit thicker CIMT than subjects with scores above the median. As the oxidative modification hypothesis of atherosclerosis suggests, it is the accumulation of the oxidized LDL-C, not the native state of LDL-C, that is atherogenic \[[@B4]\]. This is consistent with our finding that the association between the RBLS and CIMT was independent of the conventional atherosclerosis risk factors such as LDL-C. While others have reported associations between CIMT, individual lifestyle behaviours, and a seven-point cardiovascular health score \[[@B42]--[@B45]\], to the best of our knowledge, this is the first study to report the association between a composite redox balance lifestyle score and CIMT.

We observed a significant positive association between the RBLS and total antioxidant capacity (TAC) that was independent of age in males but not in females. Consistent with this finding, in one study, the combination of both physical activity and adherence to a healthy diet was associated with high plasma TAC values \[[@B17]\]. We also observed a significant negative association between the RBLS and plasma lipid hydroperoxide levels, which was independent of age and gender. Similar to our finding, Lakkur et al. showed that their suggested oxidative balance score (OBS) was inversely associated with lipid peroxidation biomarker of F2-isoprostanes \[[@B18]\].

As anticipated, our results showed a strong positive association between the RBLS and the TAC/HPX ratio, an effective index of redox balance, which was independent of age and gender. This supports the view that various lifestyle behaviours may synergistically shift the body\'s biochemistry toward an imbalanced redox state and consequent oxidative stress. While no study has yet reported associations between TAC/HPX ratio and a comprehensive lifestyle score, our lab has previously reported on the correlation between individual lifestyle components and the TAC/HPX ratio, a redox balance index, using the same cohort \[[@B33]\].

Elevated plasma GGT levels have been suggested as an early biomarker of oxidative stress \[[@B46]\] and more importantly are associated with CIMT \[[@B47]\]. Consistent with this, we found a significant negative association between the RBLS and plasma GGT levels that was independent of age and gender. In agreement with this finding, in one study, a negative association was reported between an oxidative balance score (comprising BMI, nutrition, physical activity, and smoking components) and plasma GGT levels \[[@B19]\].

Elevated plasma uric acid levels have been shown to possess prooxidant properties in CVD \[[@B48]\] and also to be an independent risk factor for increased CIMT \[[@B49]\]. We were therefore not surprised to find a significant negative association between the RBLS and plasma uric acid levels. Consistent with this finding, one study has previously reported significant associations between plasma uric acid levels and individual lifestyle components such as BMI, nutrition, and physical activity \[[@B50]\].

It is recognized that oxidative stress and inflammation are interrelated. Oxidative stress can trigger an inflammatory response, which, in turn, can be a direct inducer of oxidative stress \[[@B51], [@B52]\]. Consistent with this, we observed a significant negative association between the RBLS and the plasma inflammatory marker IL-1*β* and also a significant negative association between the RBLS and the acute-phase plasma inflammatory protein CRP, which were both dependent on age and gender. Similarly, Lakkur et al. showed a significant association between an oxidative balance score (OBS) and plasma CRP \[[@B53]\].

Our results showed that the RBLS was associated not only with oxidative stress and inflammatory biomarkers but also with routine pathology lipid biomarkers. Significant negative associations were observed between the RBLS and plasma levels of total cholesterol and LDL-C that were both independent of age and gender. This finding is consistent with the results of a population-based study by Lakkur et al. in which OBS was significantly associated with plasma total cholesterol and LDL-C \[[@B53]\]. Consistent with Lakkur et al. \[[@B53]\], our data also showed no significant association between the RBLS and plasma HDL-C. We observed a strong negative association between the RBLS and plasma TG levels that was independent of age and gender. Similarly, in one study, a healthy lifestyle score (comprising BMI, nutrition, physical activity, and smoking components) was reported to be negatively associated with plasma TG in young Australian adults \[[@B54]\].

We observed a statistically significant negative association between the RBLS and plasma glucose, independent of age and gender, and HbA1c, which was dependent on age and gender. A number of other studies have shown a negative association between lifestyle scores (comprising components such as BMI, nutrition, and physical activity) and plasma glucose and HbA1c levels \[[@B54]--[@B56]\]. These results suggest an interrelationship between oxidative stress and plasma biomarker levels in response to lifestyle.

In further support of the role for oxidative stress in the development of CVD and related comorbidities, we observed strong negative and independent associations between the RBLS and surrogate markers of insulin resistance, triglyceride to HDL-C ratio (TG/HDL-C), and TyG index \[[@B22], [@B57]\]. Consistent with this finding, other studies have shown negative associations between healthy lifestyle scores (comprising components such as BMI, nutrition, and physical activity, smoking, social support, and sleep) and plasma levels of insulin \[[@B54], [@B55], [@B58]\].

In light of findings from a recent study in which more than half of the CIMT variance was not explained by conventional cardiovascular risk factors, additional contributors need to be identified \[[@B3]\]. Oxidative stress biomarkers have been previously shown to be significantly associated with the risk of atherosclerosis and increased CIMT after controlling for conventional risk factors of atherosclerosis \[[@B7]\]. As the RBLS in our study was associated with the risk of higher CIMT independent of conventional CVD risk factors and was also associated with oxidative stress biomarkers, it can be suggested that oxidative stress biomarkers may contribute to this role. Lifestyle factors with more prooxidant and less antioxidant properties can synergistically work together to shift the body\'s biochemistry toward a state of oxidative stress, which can cause subclinical changes in CIMT and gradually lead to the tissue remodelling associated with CVD.

While the conclusions in this study are robust, our study had some limitations. First, the cross-sectional design of the study does not allow confirmation of causality, but can generate hypotheses and thus stimulate future research. Also the relatively small number of subjects may decrease the sensitivity for identification of relationships with small effect sizes. Future longitudinal studies overcoming these limitations are required to verify the consistency of our observations. As lifestyle behaviour information was self-reported, measurement error and misclassification may occur. While validated questionnaires were applied to lessen such limitations, assessing exposures over a four-month period was another limitation of this study when long-term exposures may be more relevant to the development of atherosclerosis. Therefore, future studies overcoming these limitations are recommended.

5. Conclusion {#sec5}
=============

In this study, for the first time, we showed significant associations between a composite redox balance lifestyle score (RBLS), risk for increased CIMT, and biomarkers of oxidative stress and inflammation in otherwise healthy subjects. Our findings provide further support for the role of multiple lifestyle factors influencing oxidative activity and the development of CVD. This suggests that monitoring oxidative activity may help with early identification of individuals at risk of CVD, allowing the institution of on-time, targeted, lifestyle-linked risk modifications.

This study was funded by internal funding from the Australasian Research Institute and student-allocated funding from the University of New South Wales.
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###### 

RBLS\'s point assignment scheme.

  Lifestyle component                            Correlation coefficient with TAC/HPX ratio                                                           
  ---------------------------------------------- ------------------------------------------------ -------------------------- ------------------------ -----------
  *Energy storage (0.11--0.33 points)^*γ*^*                                                                                                           
  VAT fat mass (g)                               1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    −0.11^a^
  *Nutritional factors (1.4--4.2 points)*                                                                                                             
  PUFA intake                                    1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    0.14^a^
  Trans-FA intake                                1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    −0.05
  Iron intake                                    1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    0.10
  Vitamin E intake                               1 = low (1st tertile) or higher than 270 mg^†^   2 = medium (2nd tertile)   3 = high (3rd tertile)   0.19^a^
  Vitamin C intake                               1 = low (1st tertile) or higher than 500 mg^†^   2 = medium (2nd tertile)   3 = high (3rd tertile)   0.09
  *α*-Carotene intake                            1 = low (1st tertile) or higher than 15 mg^†^    2 = medium (2nd tertile)   3 = high (3rd tertile)   0.29^∗^
  *β*-Carotene intake                            1 = low (1st tertile) or higher than 15 mg^†^    2 = medium (2nd tertile)   3 = high (3rd tertile)   0.19^a^
  Lycopene intake                                1 = low (1st tertile) or higher than 15 mg^†^    2 = medium (2nd tertile)   3 = high (3rd tertile)   0.04
  Lutein and zeaxanthin intake                   1 = low (1st tertile) or higher than 15 mg^†^    2 = medium (2nd tertile)   3 = high (3rd tertile)   0.17
  *β*-Cryptoxanthine intake                      1 = low (1st tertile) or higher than 15 mg^†^    2 = medium (2nd tertile)   3 = high (3rd tertile)   0.14
  *Common social drug use (0.44--1.32 points)*                                                                                                        
  Caffeine intake                                1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    −0.28^a∗^
  Alcohol intake                                 1 = high (\>1 drink/day)                         2 = medium (1 drink/day)   3 = low (None)           −0.14^a^
  Smoking history                                1 = current smoker                               2 = previous smoker        3 = never smoker         −0.02^a^
  *Physical activity (0.38--1.14 points)*                                                                                                             
  Physical activity                              1 = sedentary/low                                2 = moderate               3 = high                 0.17
  Sitting time                                   1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    −0.21^a∗^
  *Psychological factors (0.34--1.02 points)*                                                                                                         
  Depression score                               1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    −0.18
  Stress score                                   1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    −0.09
  Anxiety score                                  1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    0.07
  *Sleep quality (0.52--1.56 points)*                                                                                                                 
  PSQI                                           1 = high (3rd tertile)                           2 = medium (2nd tertile)   3 = low (1st tertile)    −0.25^∗^
  Apnoea risk                                    1 = high                                                                    3 = low                  0.27^a∗^

TAC: total antioxidant capacity; HPX: hydroperoxide; VAT: visceral adipose tissue; PUFA: polyunsaturated fatty acids; PSQI: Pittsburgh sleep quality index. Comparisons were made using Pearson\'s correlation unless otherwise stated; ^a^comparisons were made using Spearman\'s correlation; ^∗^*P* \< 0.05; ^*γ*^points were calculated by multiplying the point value of each lifestyle component by the (absolute) correlation coefficient of the association between the relevant component and plasma redox balance index of TAC/HPX ratio; ^†^the level previously linked to oxidative activity \[[@B34], [@B35]\].

###### 

Participant characteristics for individual components of the RBLS and their association with the RBLS.

  Characteristic                            *n*   Mean ± SD           Correlation coefficient with RBLS
  ----------------------------------------- ----- ------------------- -----------------------------------
  Lifestyle score (RBLS)                    100   6.69 ± 0.90         ---
  Age                                       100   55.98 ± 8.83        −0.09
  VAT fat mass (g)                          97    953.12 ± 798.26     −0.27^∗^
  PUFA intake (g/day)                       99    11.5 ± 5.65         0.12
  Trans FA intake (g/day)                   100   0.38 ± 0.31         −0.05
  Iron intake (mg/day)                      99    12.13 ± 4.44        −0.05
  Vitamin E intake (mg/day)                 99    7.09 ± 2.83         0.32^∗^
  Vitamin C intake (mg/day)                 97    105.54 ± 46.80      0.37^∗^
  *α*-Carotene intake (*μ*g/day)            99    714.03 ± 418.73     0.48^∗^
  *β*-Carotene intake (*μ*g/day)            99    3784.80 ± 1819.34   0.51^∗^
  Lycopene intake (*μ*g/day)                99    5143.93 ± 2639.29   0.04
  Lutein and zeaxanthin intake (*μ*g/day)   100   1011.88 ± 447.43    0.50^∗^
  *β*-Cryptoxanthine intake (*μ*g/day)      98    236.27 ± 172.67     0.38^∗^
  Caffeine intake (mg/day)                  98    303.06 ± 320.63     −0.40^∗a^
  Alcohol intake (g/day)                    99    7.57 ± 10.72        −0.32^∗a^
  *Smoking history*                         100                       −0.17^a^
  Current smoker                                  0                   
  Ever smoker                                     74                  
  Never smoker                                    26                  
  *Physical activity (%)*                   100                       0.28^∗a^
  Sedentary/low                                   20                  
  Moderate                                        43                  
  High                                            35                  
  Sitting time (min/day/week)               99    399.78 ± 154.34     −0.21^∗a^
  Depression score                          98    2.46 ± 3.01         −0.38^∗a^
  Stress score                              99    4.76 ± 3.25         −0.32^∗a^
  Anxiety score                             99    1.56 ± 1.76         −0.15^a^
  PSQI                                      97    4.34 ± 2.95         −0.50^∗a^
  *Apnoea risk (%)*                         100                       0.44^∗a^
  High risk                                       20                  
  Low risk                                        80                  

RBLS: redox balance lifestyle score; VAT: visceral adipose tissue; PUFA: polyunsaturated fatty acids; PSQI: Pittsburgh sleep quality index. Comparisons were made using Pearson\'s correlation unless otherwise stated; ^a^comparisons were made using Spearman\'s correlation; ^∗^*P* \< 0.05.

###### 

Mean carotid intima-media thickness (CIMT) and logistic regression analysis for the association between an RBLS of ≤6.68 and the chance of CIMT \> 0.70 mm.

              Mean ± SD (*n* = 98)
  ----------- ----------------------
  CIMT (mm)   0.76 ± 0.18

            OR (95% CI)          *P* value   *R* ^2^   *χ* ^2^
  --------- -------------------- ----------- --------- ---------
  Model A   4.11 (1.57--10.75)   0.004       28.6%     23.61
  Model B   3.60 (1.19--10.88)   0.023       42.4%     35.60

Model A: adjusted for age and gender; model B: adjusted for age, gender, systolic blood pressures, diastolic blood pressures, low-density lipoprotein cholesterol, estimated glomerular filtration rate (eGFR), fasting plasma glucose, and triglyceride/high-density lipoprotein cholesterol ratio; RBLS: redox balance lifestyle score.

###### 

Correlation coefficients and *P* values for the associations between RBLS and plasma biomarkers of oxidative stress, inflammation, and other biochemical markers.

                                Correlation coefficient   *P* value
  ----------------------------- ------------------------- -----------
  Oxidative stress biomarkers                             
  TAC (mmol/L)                  0.28                      0.006
  HPX (mmol/L)                  −0.28^a^                  0.005
  GGT (U/L)                     −0.23                     0.024
  Uric acid (mmol/L)            −0.20                     0.045
  TAC/HPX                       0.41                      ≤0.001
  *Inflammatory biomarkers*                               
  IL-1*β* (pmol/L)              −0.21                     0.040
  CRP (mg/L)                    −0.25^a^                  0.012
  TNF-*α* (pmol/L)              −0.06                     NS
  IL-6 (pmol/L)                 −0.10^a^                  NS
  *Other biochemical markers*                             
  TC (mmol/L)                   −0.34                     ≤0.001
  LDL-C (mmol/L)                −0.32                     0.001
  HDL-C (mmol/L)                0.12                      NS
  TG (mmol/L)                   −0.32^a^                  0.002
  FPG (mmol/L)                  −0.30                     0.003
  HbA1c (mmol/mol)              −0.23                     0.025
  TG/HDL                        −0.27                     0.008
  TyG index                     −0.40                     ≤0.001

RBLS: redox balance lifestyle score; TAC: total antioxidant capacity; HPX: hydroperoxide; GGT: *γ*-glutamyltransferase; IL-1*β*: interleukin-1*β*; CRP: C-reactive protein; TNF-*α*: tumour necrosis factor-*α*; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglyceride; FPG: fasting plasma glucose; HbA1c: glycated hemoglobin A. Comparisons were made using Pearson\'s correlation unless otherwise stated; ^a^comparisons were made using Spearman\'s correlation.
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